Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/Ⅳ

Clinical trial NCT01501149 · UNKNOWN

Trial details

NCT number: NCT01501149
Sponsor: Mingzhi Zhang
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Nasal and Nasal-type NK/T-cell Lymphoma

Start date: 2011-01-01
Primary completion: 2015-12-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.